Gabapentin

Product NDC: 68071-4099
Requested package NDC: 68071-4099-4
11-digit product format: 680714099
Labeler code: 68071
Product ID: 68071-4099_bb2cb8c2-5ad0-67fb-e053-2a95a90ad1fb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: GABAPENTIN
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: NuCare Pharmaceuticals,Inc.
Application: ANDA203244
Marketing category: ANDA
Marketing start: 2014-01-11
Marketing end: 0000-00-00
Substance: GABAPENTIN
Active strength: 600 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68071-4099	68071-4099-4	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203244-001	GABAPENTIN	GABAPENTIN	800MG	TABLET / ORAL	AB1		2013-07-12
A203244-002	GABAPENTIN	GABAPENTIN	600MG	TABLET / ORAL	AB1		2013-07-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A203244-001	AB1
A203244-002	AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB1	2013-07-12	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB1	2013-07-12	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203244-001	GABAPENTIN	800MG	TABLET / ORAL	AB	2013-07-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A203244-002	GABAPENTIN	600MG	TABLET / ORAL	AB	2013-07-12	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203244-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203244-002	AB1	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203244-001	AB1	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203244-002	AB1	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203244-001	AB1	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203244-002	AB1	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203244-001	AB1	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203244-002	AB1	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203244-001	AB1	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203244-002	AB1	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203244-001	AB1	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203244-002	AB1	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203244-001	AB1	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203244-002	AB1	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203244-001	AB1	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203244-002	AB1	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203244-001	AB1	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203244-002	AB1	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203244-001	AB1	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203244-002	AB1	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203244-001	AB1	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203244-002	AB1	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203244-001	AB1	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203244-002	AB1	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203244-001	AB1	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203244-002	AB1	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203244-001	AB1	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A203244-002	AB1	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203244-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203244-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203244-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203244-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203244-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203244-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203244-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203244-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203244-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A203244-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203244-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A203244-002	AB	1	`782e0a99824c…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
68071-4099-2	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-3	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-4	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-6	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-7	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-8	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-9	2024-07-18	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-2	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-3	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-4	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-6	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-7	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-8	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-9	2023-01-30	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-2	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-3	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-4	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-6	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-7	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-8	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-9	2021-02-12	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-2	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-3	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-4	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-6	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-7	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-8	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-4099-9	2021-01-29	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	REMEDYREPACK INC.	07c8bb17-9bd4-4fab-994d-0412205b53b4	2026-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	b6db5ce9-bd4b-420d-88a7-df9d46144c81	2026-07-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Strides Pharma Science Limited	bec31452-b52b-4698-ba4c-0b614780ee84	2025-11-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	7d3fc163-25f0-2c61-e053-2991aa0a76e9	2025-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
GABAPENTIN	GABAPENTIN	DIRECT RX	a7e45e3f-e382-32ba-e053-2a95a90a2537	2025-01-17		Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	6e6b9d8f-9f9e-4760-96ea-fb8b0a3bbbdb	2024-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	47f2a06f-4eac-4dca-aa2a-a36dd4daaea0	2024-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	b4954172-5439-48fd-8348-8a2e0d2fee62	2024-04-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	c9944562-563a-423d-972c-f0313375d234	2024-04-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	56967a93-b3c0-4043-9241-585fc64e2624	2023-12-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	0eb27e64-1488-4083-82c7-cebb8c0605de	2023-12-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	ACI Healthcare USA, Inc.	d7646d5e-ca25-4ec5-9e4b-931edcb15a0e	2023-12-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	39149f0e-30ed-4671-8be7-2a484f65d63b	2020-08-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Proficient Rx LP	8b2f38ef-0a0c-45cc-88ca-cc086bf80641	2020-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	ba2a8352-5776-4edb-914e-ce1d18ccda32	2020-05-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244
Gabapentin	GABAPENTIN	Proficient Rx LP	c09c66fd-cb31-41dd-b00b-acc58bd809f7	2020-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203244 application number: ANDA203244

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
68071-4099-4	68071409904	14 TABLET, FILM COATED in 1 BOTTLE (68071-4099-4)	2017-09-19	0000-00-00	No	No	Current